Company Short-Term Debts: Avidity Biosciences (RNA)

Avidity Biosciences Inc (RNA) - corporate logo

Avidity Biosciences (RNA) is actively implementing breakthrough AOC conjugates for the therapy of muscular dystrophies. The organization's short-term debt clearly illustrates this growth, with the current amount standing at 0.00. The company relies on the synergy of leading chemists and biologists to create an environment of scientific exploration. Meanwhile, the diversification of its RNA drug portfolio effectively minimizes financial risks during clinical trials.

aviditybiosciences.com (RNA) Company Short-Term Indebtedness: for the period 07/04/2022 - 10/28/2026

RNA (Avidity Corp): analytical breakdowns and indicator data

- price and consensus price forecast:
Stock Quotes Avidity Biosciences, Inc.|RNA - Price Target Chart
- market capitalization data:
Market Capitalization Avidity Biosciences, Inc.|RNA - Company Buyout Price
- book capitalization data:
Book Value per Share Avidity Biosciences|RNA - Accounting Capitalization|Market Capitalization to Book Value Ratio aviditybiosciences.com|RNA - Company Total Asset Base
- debt and liquidity data:
Total Debt to Equity Ratio Avidity Biosciences|RNA - Long-Term Loans to Capital Ratio|Short-Term Debt to Equity Ratio Avidity Biosciences|RNA - Company Cumulative Debt|Debt to Book Value Avidity Biosciences, Inc.|RNA - Company Long-Term Loans and Borrowings|Company Short-Term Debts Avidity Biosciences
Initial company analysis:RNA Avidity Biosciences, Inc.
Original product of aviditybiosciences.com

For Avidity Biosciences (RNA), which competes in the biotech sector through unique patents, the amount of short-term financial debt reflects the current pressure on working capital. This metric aggregates all liabilities with a maturity of up to one year, allowing investors to assess liquidity and the company's ability to fund innovative developments without the risk of a sudden loss of solvency.

Competitors of Avidity Biosciences (RNA)

TEM - Company Current Liabilities|QGEN - Company Short-Term Debt|Ionis Pharma - Company Short-Term Debts|Repligen Inc. (RGEN) - Short-Term Debt Volume|Company Short-Term Debts CRISPR Therapeutics AG (CRSP)|Company Short-Term Indebtedness genedx.com|RARE (Ultragenyx) - Company Short-Term Debts|Short-Term Debt Volume Beam Therapeutics Inc BEAM|Company Current Liabilities Sarepta Therapeutics Inc (SRPT)|TWST - Amount of Current Liabilities|TXG (10x Genomics, Inc.) - Company Current Liabilities|intelliatx.com (NTLA) - Short-Term Debt|Company Current Liabilities Stoke Therapeutics, Inc. STOK|BioLife Solutions Inc (BLFS) - Company Short-Term Loans and Borrowings|Company Short-Term Debts Wave Life Sciences Corp|Company Short-Term Debt Maze Therapeutics Corp|SION (Sionna Therapeutics Inc) - Company Short-Term Debts|Short-Term Debt Volume PRME (primemedicine.com)|TSHA: Company Short-Term Debt|uniQure NV - Short-Term Debt|Company Short-Term Debt MGTX (MeiraGTx PLC)|RGNX - Short-Term Debt Volume|SLDB (Solid Biosciences Inc.) - Company Short-Term Debts|ocugen.com (OCGN) - Company Current Liabilities|PACB: Company Short-Term Debts|Short-Term Debt Volume Benitec Biopharma Inc|Design Pharma - Company Short-Term Debts|Short-Term Debt RCKT (Rocket Corp)|FDMT - Company Short-Term Debt|Company Short-Term Indebtedness Lexeo Therapeutics Inc. LXEO|KRRO: Company Short-Term Debts|EDIT - Company Current Liabilities|Company Short-Term Debts SLN|PRQR (ProQR Therapeutics) - Short-Term Debt|CDXS: Company Short-Term Debt|Short-Term Debt Volume SGMO|Nautilus Biotechnology (NAUT) - Company Short-Term Debt|Company Short-Term Loans and Borrowings MGX (Metagenomi Inc.)|DTIL - Company Short-Term Debt|Company Short-Term Indebtedness Generation Bio Co GBIO|Boundless Bio, Inc. - Company Short-Term Debts|XCUR - Company Short-Term Debts|Company Short-Term Debts imunon.com|PHIO (Phio Pharmaceuticals Corp.) - Company Short-Term Indebtedness|Company Short-Term Debt Mustang Bio Inc (MBIO)|Company Short-Term Indebtedness TransCode|Company Short-Term Debts BNGO|Company Short-Term Debts adnas.com (APDN)|Company Short-Term Debts BLUE (bluebird bio)|IPA - Company Short-Term Debts|OMGA - Company Current Liabilities|OMIC - Company Short-Term Debt|Regulus Therapeutics - Company Short-Term Debts|syros.com (SYRS) - Short-Term Debt Volume|Company Short-Term Debts Telesis Bio (TBIO)|Company Short-Term Indebtedness TRACON Pharmaceuticals Inc.|UBX (Unity Bio) - Company Short-Term Debts